A team of investigators led by Chaofeng Ma of Xi’an Center for Disease Control and Prevention hypothesized that viral inactivation may contribute to false negatives. They have now tested several inactivation methodologies to determine if and to what extent they reduce detectible virus in a clinical sample. The research appears May 29th in the Journal of Clinical Microbiology, a publication of the American Society for Microbiology.
- Oncotarget: Evaluation of cellular alteration & inflammatory profile of cells
- Cause of Alzheimer’s disease traced to mutation in common enzyme
- Elkhorn coral actively fighting off diseases on reef, study finds
- Mary Ann Liebert, Inc. to publish Journal of Correctional Health Care
- Exploring the source of stars and planets in a laboratory